Mononucleosis News and Research

RSS

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

Antigens produced by the Epstein Barr virus may provide an ideal target for cancer therapy

A typically innocuous virus found in 90 percent of people worldwide is the key to a new treatment for a cancer particularly common in North Africa and Southeast Asia.

16 Feb 2005

Exposure to infant siblings decreases multiple sclerosis risk

Exposure to infant siblings decreases multiple sclerosis risk

Adults who report having had higher exposure to infant siblings during their first 6 years of life have a reduced risk of multiple sclerosis (MS), according to a study in the January 26 issue of JAMA.

26 Jan 2005

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Day care or nursery school attendance may reduce risk of developing Hodgkin's disease

Young adults who attended day care or nursery school when they were children were more than a third less likely to develop Hodgkin's disease, according to a new study by Harvard School of Public Health researchers.

25 Aug 2004

Drug to fight virus from the herpes family in transplant patients moves forward in trials

Drug to fight virus from the herpes family in transplant patients moves forward in trials

A drug once considered for cancer chemotherapy is advancing in clinical trials to test its effectiveness in fighting a virus from the herpes family that threatens transplant patients.

29 Jul 2004

Previous
1
...
5
6
7
8

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.